Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.

Lopez-Gonzalez, R; Loza, E; Jover, J A; Benitez Del Castillo, J M; Mendez, R; Hernandez-Garcia, C; Pato, E

Lopez-Gonzalez, R; Loza, E; Jover, J A; Benitez Del Castillo, J M; Mendez, R; Hernandez-Garcia, C; Pato, E.

Affiliation

Lopez-Gonzalez R; Rheumatology Unit, Hospital Clinico San Carlos, Madrid, Spain.

Scand J Rheumatol ; 38(1): 58-62, 2009.

Article in En | MEDLINE | ID: mdl-18991187

Subject(s)

Antibodies, Monoclonal/therapeutic use; Antirheumatic Agents/therapeutic use; Uveitis, Posterior/drug therapy; Adult; Aged; Antibodies, Monoclonal/adverse effects; Antirheumatic Agents/adverse effects; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infliximab; Longitudinal Studies; Male; Middle Aged; Scleritis/drug therapy; Scleritis/physiopathology; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Uveitis, Posterior/physiopathology; Visual Acuity/physiology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Uveitis, Posterior / Antirheumatic Agents / Antibodies, Monoclonal Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2009 Type: Article

Fulltext

XML

PubMed Links

Search on Google